Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of ...

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

As more people turn to semaglutides, such as Ozempic and Mounjaro, to shift unwanted pounds, pre-loved clothing sites such as ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.